India's Pharmaceutical Exports

Country Profile

Belarus

Belarus is an emerging destination for Indian pharmaceutical exports — $28.9M in FY 2025–26, with 1.9× growth over the past decade. Medicines accounts for 75% of shipments, with vaccines contributing $807K. The compound annual growth rate since FY2015 stands at 5.9%.

🇧🇾 $28.9M · 1.9× growth since FY2015 · 5.9% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$28.9M
Exports FY2025–26 DGCIS
1.9×
Growth FY2015→2026
5.9%
CAGR FY2015→2026
75%
Medicines Share
5
Product Categories Supplied
Belarus is an emerging destination for Indian pharmaceutical exports — $28.9M in FY 2025–26, with 1.9× growth over the past decade. Medicines accounts for 75% of shipments, with vaccines contributing $807K. The compound annual growth rate since FY2015 stands at 5.9%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $21.8M (75.3%) Medicine Ingredients $5.02M (17.4%) Surgical & Hospital Supplies $1.03M (3.6%) Vaccines $807K (2.8%) Traditional & Herbal $273K (0.9%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Belarus in the RBI overseas direct investment dataset (2011–2026).